VOLITIONRX LTD (VNRX): Unregistered Sales of Equity Securities

VOLITIONRX LTD (VNRX) filed an SEC Form 8-K — Results of Operations and Financial Condition. vnrx_8k.htm 0000093314 false 0000093314 2026-08-13 2026-08-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 D

VolitionRx Limited (NYSE American: VNRX) reported Q2 2026 revenue of about $0.4 million, flat versus Q2 2025, and first-half 2026 revenue of $1.4 million, up 112% year over year. Operating expenses fell 32% and operating loss was $4.2 million. The company said it is discussing licensing deals, including a Sysmex collaboration, and expects a $5 million milestone from a Nu.Q Vet feline assay peer review.

JPMorgan (JPM) and Santander are leading a $14B-$15B financing effort for Argentina LNG, a $24B project to export Argentina's shale gas. Partners include YPF, Eni, and XRG, with a final investment decision expected in late November. The project exceeds Argentina's $20B IMF agreement.

Boeing (NYSE:BA) won a $131.23B contract for F-15 aircraft production, upgrades, and maintenance, with work through 2037. The deal includes Foreign Military Sales to multiple countries. Initial funds of $343,740 are obligated. The contract was awarded by the U.S. Department of War.

Real REMAX Group Inc. (REAX) announced a $450 million share repurchase program, reflecting confidence in its long-term strategy. The timing and amount of repurchases will depend on market conditions. The company is a global real estate platform with 180,000+ agents.

Amrize Inc (AMRZ) shares dropped 3.9% after hours as CFO Baris Oran resigned. Samuel J. Poletti, former Chief Strategy and M&A Officer, will replace Oran. Poletti led Amrize's spin-off and has extensive M&A experience. Dillon Cumming was appointed VP of Investor Relations, effective September 8.